Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Bertoli

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Leukemia|November 14, 2022
Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILOPierre-Yves Dumas, Emmanuel Raffoux, Emilie Bérard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2022
Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life ExperienceVincent Marmouset, Justine Decroocq, Sylvain Garciaz, et al.
Blood|May 21, 2026
Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapyNicolas Duployez, Romane Joudinaud, Augustin Boudry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2019
Chromosomal Abnormalities and Prognosis in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International CohortsLinus Angenendt, Christoph Röllig, Pau Montesinos, et al.
Cancer Discovery|April 3, 2023
C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress-Induced Ferroptosis in FLT3-Mutant LeukemiaMarie Sabatier, Rudy Birsen, Laura Lauture, et al.
Leukemia|October 28, 2025
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patientsMarius Bill, Jan-Niklas Eckardt, Konstanze Döhner, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Leukemia|November 14, 2022
Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILOPierre-Yves Dumas, Emmanuel Raffoux, Emilie Bérard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2022
Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life ExperienceVincent Marmouset, Justine Decroocq, Sylvain Garciaz, et al.
Blood|May 21, 2026
Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapyNicolas Duployez, Romane Joudinaud, Augustin Boudry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2019
Chromosomal Abnormalities and Prognosis in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International CohortsLinus Angenendt, Christoph Röllig, Pau Montesinos, et al.
Cancer Discovery|April 3, 2023
C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress-Induced Ferroptosis in FLT3-Mutant LeukemiaMarie Sabatier, Rudy Birsen, Laura Lauture, et al.
Leukemia|October 28, 2025
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patientsMarius Bill, Jan-Niklas Eckardt, Konstanze Döhner, et al.
Pageof 10